Literature DB >> 26712809

Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.

Renata C Pereira1, David S Bischoff2, Dean Yamaguchi2, Isidro B Salusky1, Katherine Wesseling-Perry3.   

Abstract

BACKGROUND AND OBJECTIVES: Computed tomography (CT) measurements can distinguish between cortical and trabecular bone density in vivo. High-resolution CTs assess both bone volume and density in the same compartment, thus potentially yielding information regarding bone mineralization as well. The relationship between bone histomorphometric parameters of skeletal mineralization and bone density from microcomputed tomography (μCT) measurements of bone cores from patients on dialysis has not been assessed. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Bone cores from 68 patients with ESRD (age =13.9±0.5 years old; 50% men) and 14 controls (age =15.3±3.8 years old; 50% men) obtained as part of research protocols between 1983 and 2006 were analyzed by bone histomorphometry and μCT.
RESULTS: Bone histomorphometric diagnoses in the patients were normal to high bone turnover in 76%, adynamic bone in 13%, and osteomalacia in 11%. Bone formation rate did not correlate with any μCT determinations. Bone volume measurements were highly correlated between bone histomorphometry and μCT (bone volume/tissue volume between the two techniques: r=0.70; P<0.001, trabecular thickness and trabecular separation: r=0.71; P<0.001, and r=0.56; P<0.001, respectively). Osteoid accumulation as determined by bone histomorphometry correlated inversely with bone mineral density as assessed by μCT (osteoid thickness: r=-0.32; P=0.01 and osteoid volume: r=-0.28; P=0.05). By multivariable analysis, the combination of bone mineral density and bone volume (as assessed by μCT) along with parathyroid hormone and calcium levels accounted for 38% of the variability in osteoid volume (by histomorphometry).
CONCLUSIONS: Measures of bone volume can be accurately assessed with μCT. Bone mineral density is lower in patients with excessive osteoid accumulation and higher in patients with adynamic, well mineralized bone. Thus, bone mineralization may be accurately assessed by μCT of bone biopsy cores. Additional studies are warranted to define the value of high-resolution CT in the prediction of bone mineralization in vivo.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  bone biopsy; bone density; calcification, physiologic; child; humans; kidney failure, chronic; micro CT; renal dialysis; renal osteodystrophy

Mesh:

Substances:

Year:  2015        PMID: 26712809      PMCID: PMC4791816          DOI: 10.2215/CJN.04810515

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  25 in total

1.  Severe bone disease and low bone mineral density after juvenile renal failure.

Authors:  Jaap W Groothoff; Martin Offringa; Berthe L F Van Eck-Smit; Mariken P Gruppen; Nicole J Van De Kar; Eric D Wolff; Marc R Lilien; Jean Claude Davin; Hugo S A Heymans; Friedo W Dekker
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

2.  Bone disease in children and adolescents undergoing successful renal transplantation.

Authors:  C P Sanchez; I B Salusky; B D Kuizon; J A Ramirez; B Gales; R B Ettenger; W G Goodman
Journal:  Kidney Int       Date:  1998-05       Impact factor: 10.612

3.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

4.  Determination of serum calcium by use of an AutoAnalyzer I-II hybrid.

Authors:  C L Jacklyn; C D Freeman; M E Gray; M A MacAulay
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

5.  AutoAnalyzer assay for serum alkaline phosphatase activity, with sodium thymolphthalein monophosphate as substrate.

Authors:  G J Proksch; D P Bonderman; J A Griep
Journal:  Clin Chem       Date:  1973-01       Impact factor: 8.327

6.  Simplified serum phosphorus analyses by continuous-flow ultraviolet spectrophotometry.

Authors:  E Amador; J Urban
Journal:  Clin Chem       Date:  1972-07       Impact factor: 8.327

7.  Non-invasive measurements of bone mass in adult renal osteodystrophy.

Authors:  E P Boling; C Primavera; G Friedman; M King; L Bosserman; E E Schulz; W G Goodman
Journal:  Bone       Date:  1993 May-Jun       Impact factor: 4.398

8.  Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women.

Authors:  B M Misof; D W Dempster; Hua Zhou; P Roschger; N Fratzl-Zelman; P Fratzl; S J Silverberg; E Shane; A Cohen; E Stein; T L Nickolas; R R Recker; J Lappe; J P Bilezikian; K Klaushofer
Journal:  Calcif Tissue Int       Date:  2014-08-19       Impact factor: 4.333

9.  The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.

Authors:  Babul Borah; Erik L Ritman; Thomas E Dufresne; Steven M Jorgensen; Sheng Liu; Jarek Sacha; Roger J Phipps; Russell T Turner
Journal:  Bone       Date:  2005-07       Impact factor: 4.398

10.  Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone.

Authors:  Felix W Wehrli; Mary B Leonard; Punam K Saha; Bryon R Gomberg
Journal:  J Magn Reson Imaging       Date:  2004-07       Impact factor: 4.813

View more
  12 in total

Review 1.  Early clinical applications for imaging at microscopic detail: microfocus computed tomography (micro-CT).

Authors:  J Ciaran Hutchinson; Susan C Shelmerdine; Ian C Simcock; Neil J Sebire; Owen J Arthurs
Journal:  Br J Radiol       Date:  2017-05-04       Impact factor: 3.039

2.  Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.

Authors:  I D B Marques; M J C L N Araújo; F G Graciolli; L M Dos Reis; R M Pereira; M R Custódio; V Jorgetti; R M Elias; E David-Neto; R M A Moysés
Journal:  Osteoporos Int       Date:  2017-02-16       Impact factor: 4.507

3.  Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.

Authors:  Rachel M Holden; Reem A Mustafa; R Todd Alexander; Marisa Battistella; Micheli U Bevilacqua; Greg Knoll; Fabrice Mac-Way; Martina Reslerova; Ron Wald; Philip D Acott; Patrick Feltmate; Allan Grill; Kailash K Jindal; Meena Karsanji; Bryce A Kiberd; Sara Mahdavi; Kailee McCarron; Amber O Molnar; Maury Pinsk; Celia Rodd; Steven D Soroka; Amanda J Vinson; Deborah Zimmerman; Catherine M Clase
Journal:  Can J Kidney Health Dis       Date:  2020-08-04

Review 4.  Kidney Disease and Bone: Changing the Way We Look at Skeletal Health.

Authors:  Matthew R Allen; Elizabeth A Swallow; Corinne E Metzger
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

Review 5.  Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2019-12-10       Impact factor: 3.714

6.  Proportional vascularization along the fallopian tubes and ovarian fimbria: assessment by confocal microtomography.

Authors:  Pedro Teixeira Castro; Osvaldo Luiz Aranda; Edson Marchiori; Luiz Felipe Bittencourt de Araújo; Haimon Diniz Lopes Alves; Ricardo Tadeu Lopes; Heron Werner; Edward Araujo Júnior
Journal:  Radiol Bras       Date:  2020 May-Jun

Review 7.  Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available?

Authors:  A D Lalayiannis; N J Crabtree; M Fewtrell; L Biassoni; D V Milford; C J Ferro; R Shroff
Journal:  Pediatr Nephrol       Date:  2019-06-25       Impact factor: 3.714

8.  Regulation of osteoblast behaviors via cross-talk between Hippo/YAP and MAPK signaling pathway under fluoride exposure.

Authors:  Wen-Qing Zhu; Ying-Juan Yu; Li-Na Xu; Pan-Pan Ming; Shui-Yi Shao; Jing Qiu
Journal:  J Mol Med (Berl)       Date:  2019-05-04       Impact factor: 4.599

9.  Magnesium-alloy rods reinforced bioglass bone cement composite scaffolds with cortical bone-matching mechanical properties and excellent osteoconductivity for load-bearing bone in vivo regeneration.

Authors:  Huyang Duan; Chuanliang Cao; Xiaolei Wang; Jun Tao; Chen Li; Hongbo Xin; Jing Yang; Yulin Song; Fanrong Ai
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

Review 10.  Bone Fragility Fractures in CKD Patients.

Authors:  Ana Pimentel; Pablo Ureña-Torres; Jordi Bover; Jose Luis Fernandez-Martín; Martine Cohen-Solal
Journal:  Calcif Tissue Int       Date:  2020-11-21       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.